Recurrent Nighttime Falls in an 84-Year-Old Taking Three Sedating Drugs
An 84-year-old woman has fallen twice in six weeks, both times at night while walking to the bathroom. She lives alone in a second-floor walk-up and uses a cane indoors. Her son brings her in after the second fall, which caused a bruised hip but no fracture. Medications: amitriptyline 50 mg at bedtime, oxybutynin 10 mg daily, zolpidem 10 mg at bedtime, lisinopril 20 mg, metoprolol succinate 50 mg, omeprazole 20 mg, calcium with vitamin D. She has hypertension, knee osteoarthritis, urge incontinence, insomnia and mild depression. Blood pressure is 148/78 lying and 120/68 after one minute standing. She rises slowly from a chair, gait is slow and wide-based, and Timed Up and Go is 18 seconds. She is cognitively intact. Sodium is 134, creatinine 1.1 mg/dL, eGFR 52. She insists the sleeping pill and amitriptyline are the only things that help her sleep.
1. Which of her medications most likely contribute to her falls, and in what order would you address them? Explain your reasoning.
Read the worked answer
Three agents account for most of her fall risk, and each appears on the Beers list:
- Zolpidem 10 mg - sedative-hypnotic with peak impairment in the first hours after dosing, exactly when she walks to the bathroom. Highest immediate risk, and the easiest to justify stopping.
- Amitriptyline 50 mg - anticholinergic plus alpha-1 blockade, producing orthostasis, sedation, and slowed processing; also a plausible contributor to her sodium of 134 through SIADH.
- Oxybutynin 10 mg - strongly anticholinergic, sedating, and additive with amitriptyline.
- Lisinopril and metoprolol contribute to the 28 mmHg orthostatic drop, though they are less likely to be the primary cause.
Sequence: stop zolpidem first, substituting CBT-I, then taper amitriptyline over 4–6 weeks while watching sleep and mood - mirtazapine is a poor substitute because it is sedating and orthostatic. Replace oxybutynin with behavioral therapy and, if needed, a beta-3 agonist. Reduce the orthostatic burden by reviewing antihypertensive timing and dose. Change one drug at a time so that cause and effect remain visible, and recheck standing blood pressure and sodium.
2. What non-drug interventions and follow-up would you build into the plan?
Read the worked answer
Non-drug measures are not optional here; they are the treatment.
- Nocturia pathway: bedside commode, night light along the route, removal of rugs and cords, no fluids after 6 pm, and review of antihypertensive timing, since evening dosing can worsen nocturia.
- Gait and balance: physical therapy referral for a home-based strength and balance program (Otago-type), cane fitting, and footwear with non-slip soles.
- Orthostasis: rise in stages, sit at the edge of the bed for a minute, maintain hydration, consider compression stockings, and recheck standing vital signs at each visit.
- Senses and environment: vision check for cataract or refraction change, grab bars in the bathroom, and a personal emergency response system given that she lives alone on a second floor.
- Bone health: DEXA, vitamin D, and treatment of osteoporosis if present, because the next fall may be a fracture rather than a bruise.
- Follow-up: 2–4 weeks with a fall diary and a planned review of the next medication. Ask specifically about fear of falling, which predicts inactivity and further decline.
3. She refuses to stop amitriptyline. How do you proceed?
Read the worked answer
Refusal is common and is not a reason to abandon the conversation. Start by asking what the amitriptyline does for her - likely sleep and mood - and reflect that back so she feels heard rather than managed. Then give a concrete risk statement rather than a vague warning: three sedating or anticholinergic drugs together substantially raise her chance of another fall, and she has already had two.
Offer a substitute for the function she values. CBT-I has stronger and more durable evidence than zolpidem for insomnia in older adults. If an antidepressant is still needed, a low-dose SSRI with sodium monitoring is safer than a tricyclic, though it carries its own hyponatremia risk given her sodium of 134.
Propose a time-limited trial - a slow taper over six weeks with a sleep diary and a scheduled check-in - rather than a permanent decision. If she still declines, document her reasoning and her capacity, continue every other risk-reduction step, and revisit at the next visit or after any further fall. Preserving trust matters more than winning this visit.